Related references
Note: Only part of the references are listed.High Fiber and Low Starch Intakes Are Associated with Circulating Intermediate Biomarkers of Type 2 Diabetes among Women
Hala B. AlEssa et al.
JOURNAL OF NUTRITION (2016)
Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction
Hadi Khodabandehloo et al.
TRANSLATIONAL RESEARCH (2016)
α-Galacto-oligosaccharides Dose-Dependently Reduce Appetite and Decrease Inflammation in Overweight Adults
Fanny B. Morel et al.
JOURNAL OF NUTRITION (2015)
Potential role of the intestinal microbiota in programming health and disease
Olivier Goulet
NUTRITION REVIEWS (2015)
Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial
Parvin Dehghan et al.
NUTRITION (2014)
Potential Benefits of Weight Loss in Coronary Heart Disease
Philip A. Ades et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2014)
Diabetes, obesity and gut microbiota
Amandine Everard et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2013)
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women
Evelyne M. Dewulf et al.
GUT (2013)
Obesity, Inflammation and Diet
Hansongyi Lee et al.
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2013)
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Michele Malaguarnera et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
Valentina Volynets et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Jill A. Parnell et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
P. D. Cani et al.
GUT (2009)
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Patrice D. Cani et al.
DIABETES (2008)
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
P. D. Cani et al.
DIABETOLOGIA (2007)
Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease
B De Taeye et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Share Paper
